ERBB2 and pancreatic adenocarcinoma: This method enabled us to determine a threshold number of Vδ2 T cells per microliter blood below which no cytotoxic activity toward pancreatic adenocarcinoma tumor targets could be triggered by pAg or Her2-Vγ9 tribody (48).